The Cannigma

MARCH 7, 2022

When CBN was studied without barbiturates (prescription sedative medications typically used for epilepsy), the combination of CBN and THC produced greater sedation together than either cannabinoid alone. What can the current clinical trials tell us? Common cannabinoids in cannabis.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

The Cannigma

MAY 19, 2021

In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes. CBD has become especially trendy in Tokyo, where CBD shops and cafes allow for the on-site consumption of CBD in edibles and topical treatments.

Law 137

Law Legalization Clinical Trials CBD 137

Cannabis Law Report

SEPTEMBER 6, 2021

Cannabis is safer and has less severe side effects in comparison to other treatment options. It also finds usage along with other treatments either to enhance their efficacy or to combat adverse side effects. Key Topics Covered: 1 Preface. Key Topics Covered: 1 Preface. 2 Scope and Methodology. 3 Executive Summary.

Chronic Pain 86

Chronic Pain Research and Development Clinical Trials Epilepsy 86

Canna Care Docs

DECEMBER 16, 2020

It would feel like an out-of-body experience, except for one fact: your body is constantly reminding you of those symptoms you’ve been suffering from all this time, putting treatment on the back burner while you deal with life as we know it. In several clinical studies, marijuana use seemed to improve mood for those with reactive depression.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

MMJ Recs

DECEMBER 22, 2023

Medical marijuana, once a controversial and stigmatized topic, has undergone a remarkable transformation in the eyes of the American public. The AIDS epidemic in the 1980s brought attention to the potential benefits of marijuana in alleviating symptoms such as nausea and appetite loss associated with the disease and its treatment.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

The first-ever cannabis-based drug with FDA approval is Epidiolex*, a new prescription drug designed to treat severe seizure disorders that do not respond to other treatments. Epidiolex has received FDA approval to treat Dravet Syndrome and Lennox-Gestaut Syndrome; two very rare forms of epilepsy that manifest in early childhood.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. CBG, however, also has some medicinal potential that CBD doesn’t, for instance as a treatment for hypertension and insulin resistance.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Kind Meds (Cannabis Education Blog)

NOVEMBER 16, 2022

Researchers believe CBN is promising in that it may be beneficial in the treatment of some common ailments. capsule, oil, topical, edible). When CBN cream is applied to the skin of clinical trial participants, it appears to be beneficial in treating epidermolysis bullosa, a rare disease that causes blisters on the skin.

Sleep 94

Sleep Cannabinoids THC CBD 94

The Joint Blog

APRIL 22, 2022

There are multiple ways to ingest this oil; one can apply it topically, consume it through smoke inhalation or in the form of edible. Consumption of CBD through smoke inhalation or ingestion is beneficial for treating widespread pain, while topical application is recommended for alleviating pain from a specific area. Treats Epilepsy.

Oil 26

Oil CBD Topical Clinical Trials 26

CannaTech

SEPTEMBER 16, 2018

Many healthcare practitioners possess a knowledge gap about cannabis, as their medical school curriculum didn’t include any information on the topic. Over time extended clinical trials will continue to map out the plant’s therapeutic effects, supporting it as an alternative medicine offering relief for a long list of conditions.

Education 66

Education Medicine Clinical Trials Patients 66

Cannabis Law Report

FEBRUARY 3, 2022

Based on route of administration, the market is segmented into oral, topical, inhalation, rectal, sublingual. The oil segment is accounted to have the largest share in global cannabis treatment market during the forecast period. Growing Adoption of Medical Cannabis for the Treatment of Chronic Compounds. Impact Factor Analysis.

Indica 52

Indica Oil Legalization Research and Development 52

Cannabis Law Report

JANUARY 24, 2022

The CBD segment dominated the market in 2021 due to the growing awareness about the positive effects of CBD for the treatment of various medical conditions, such as chronic pain, cancer & multiple sclerosis. Key Topics Covered: Chapter 1 Methodology and Scope. Growing adoption of medical marijuana for treatment of chronic diseases.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This Epilepsy – Pipeline Insight, 2021 provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Epilepsy pipeline landscape.

Epilepsy 52

Epilepsy Clinical Trials Research and Development Pharmaceutical 52

Greencamp

AUGUST 16, 2018

The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). Exploring the available research on ALS and cannabinoids.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Epilepsy Behav. Accessed October 17, 2022. 2022;127:108514.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

SEPTEMBER 20, 2021

Nanomerics”) to use Nanomeric’s molecular envelope platform technology (MET) for the nasal delivery of a cannabidiol (CBD) for the management of epilepsy in adults and children. Epoladerm™ is a topical diclofenac metered-dose spray film formulation being developed to manage acute musculoskeletal pain and osteoarthritis.

Epilepsy 52

Epilepsy Research and Development Clinical Trials Chronic Pain 52

MGC Pharma

FEBRUARY 20, 2018

Cannabis is an effective tool for the treatment of topical skin conditions In a recent study by undertaken by MGC Pharma, our dermatologists found that CBD is effective in providing relief for relief for dry, red, flakey, oily and acne prone skin through CBD skincare.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Cannabis Law Report

OCTOBER 6, 2021

Under the terms of this agreement, Sinclair Research will perform preclinical animal studies including method, dosage and toxicity as part of the enabling trials for an Investigational New Drug Application (“IND”) for AnQlar, as required by the U.S. Virpax is initially seeking FDA approval of its three patented drug delivery platforms.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Chronic Pain 52

CannaTech

SEPTEMBER 23, 2019

This bottleneck has left patients and parents to pursue unregulated avenues to access treatment. NICE develop evidence-based guidelines on a wide range of health-related topics, including integrating novel and emerging therapies. UK cannabis policy is not serving the interests of patients.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Key Topics Covered: Chapter 1 Methodology and Scope. Chapter 2 Executive Summary. Market Segmentation.

Recreational 95

Recreational Hemp THC Legalization 95

Cannabis Law Report

DECEMBER 28, 2021

We added VRP324 which is an intranasally delivered cannabidiol (‘CBD’) formulation for the management of epilepsy in adults and children. Epoladerm™ Epoladerm is a diclofenac topical spray film product candidate that is being developed for pain associated with osteoarthritis of the knee. to conduct this study in Canada.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

DECEMBER 8, 2021

Charles River Laboratories, a renowned CRO engaged by Virpax to perform Food and Drug Administration (FDA) required pre-clinical studies, has completed a single dose pharmacokinetic study of dermal administration of Epoladerm in minipigs as part of the required Investigational New Drug Application (“IND”) enabling trials.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Topical 52

Cannabis Law Report

NOVEMBER 15, 2021

Finally, we recently acquired the worldwide rights to VRP324, which is an intranasal pharmaceutical-grade cannabidiol product candidate for the management of epilepsy in children (rare pediatric disease) and adults. VRP324 represents our first CNS disorder product indication. RECENT DEVELOPMENTS. Bruce and Michael F.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). Refractory paediatric epilepsy.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

DECEMBER 22, 2021

We have autism and epilepsy. I don’t know if we’ll have topicals initially, or later on. We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil. Cannabis is given to oncology patients, palliative patients.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

AUGUST 12, 2019

After multiphase clinical trials were completed, an FDA panel recommended approval of a CBD-based pharmaceutical called Epidiolex for treatment of certain specific and rare types of juvenile epilepsy. CBD-Infused Topicals. CBD-infused topicals include skin creams, balms, salves and oils.

CBD 40

CBD Terpenes Oil Tincture 40

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Lancet Neurol Dec 23 2015.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

OCTOBER 17, 2019

Retailers such as Walgreens, CVS, Rite Aid, Kroger, Safeway, Nordstrom, and DSW are selling or plan to sell CBD-infused topical lotions, cosmetics, and even edibles where they are legally able to do so. the form the finished product can take (edibles, topicals, etc.). how the segments are defined (e.g.,

Law 40

Law Seed-To-Sale Hemp Recreational 40